Meditelecare Of New Mexico, Llc - Medicare Mental Health Clinic in Espanola, NM

Meditelecare Of New Mexico, Llc is a medicare enrolled mental health clinic (Psychiatry & Neurology - Psychiatry) in Espanola, New Mexico. The current practice location for Meditelecare Of New Mexico, Llc is 206 S Coronado Ave, Espanola, New Mexico. For appointments, you can reach them via phone at (860) 788-6404. The mailing address for Meditelecare Of New Mexico, Llc is Po Box 1595, Middletown, Connecticut and phone number is (860) 788-6404.

Meditelecare Of New Mexico, Llc is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1629639729. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (860) 788-6404.

Contact Information

Meditelecare Of New Mexico, Llc
206 S Coronado Ave
Espanola
NM 87532-2792
(860) 788-6404
(860) 829-0495

Mental Health Clinic Profile

Full NameMeditelecare Of New Mexico, Llc
SpecialityPsychiatry & Neurology
Location206 S Coronado Ave, Espanola, New Mexico
Authorized Official Name and PositionTeresa Pearl Trojanowski (DIRECTOR OF REVENUE CYCLE)
Authorized Official Contact8607886404
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Meditelecare Of New Mexico, Llc
Po Box 1595
Middletown
CT 06457-8095

Ph: (860) 788-6404
Meditelecare Of New Mexico, Llc
206 S Coronado Ave
Espanola
NM 87532-2792

Ph: (860) 788-6404

NPI Details:

NPI Number1629639729
Provider Enumeration Date06/28/2019
Last Update Date06/28/2019

Medicare PECOS Information:

Medicare PECOS PAC ID1254668122
Medicare Enrollment IDO20190815000690

News Archive

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.

The once youngest person in the world to survive a heart by-pass operation is expecting her 2nd child

Lorraine Stone was born with heart disease. When just three days old she was the youngest person in the world at that time to survive a heart by-pass operation. Since then she has had five major heart operations. Miraculously, at the age 29, she is expecting to give birth to her second child in July.

MS Australia partners again with Jean Hailes to spotlight multiple sclerosis and women's health

Multiple sclerosis affects around three times as many women as men and is commonly diagnosed between the ages of 20 and 40 years, when many women are focusing on career and family planning.

Rockefeller University Hospital opens clinical trial into statin-associated muscle complaints

The most widely prescribed class of drugs in the country, statins have helped millions of people lower their cholesterol and reduce their risk of heart attacks - but their side effects, including muscle pain and cramping, have proven to be something of a sore point for many patients.

Read more Medical News

› Verified 7 days ago

Medical Identifiers

Medical identifiers for Meditelecare Of New Mexico, Llc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1629639729NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
103TC0700XPsychologist - Clinical (* (Not Available))Secondary
1041C0700XSocial Worker - Clinical (* (Not Available))Secondary
2084P0800XPsychiatry & Neurology - Psychiatry (* (Not Available))Primary
2084P0805XPsychiatry & Neurology - Geriatric Psychiatry (* (Not Available))Secondary
363LP0808XNurse Practitioner - Psychiatric/mental Health (* (Not Available))Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Meditelecare Of New Mexico, Llc acts as a billing entity for following providers:
Provider NameKeith B Haynie
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1033355284
PECOS PAC ID: 9436216124
Enrollment ID: I20090325000104

News Archive

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.

The once youngest person in the world to survive a heart by-pass operation is expecting her 2nd child

Lorraine Stone was born with heart disease. When just three days old she was the youngest person in the world at that time to survive a heart by-pass operation. Since then she has had five major heart operations. Miraculously, at the age 29, she is expecting to give birth to her second child in July.

MS Australia partners again with Jean Hailes to spotlight multiple sclerosis and women's health

Multiple sclerosis affects around three times as many women as men and is commonly diagnosed between the ages of 20 and 40 years, when many women are focusing on career and family planning.

Rockefeller University Hospital opens clinical trial into statin-associated muscle complaints

The most widely prescribed class of drugs in the country, statins have helped millions of people lower their cholesterol and reduce their risk of heart attacks - but their side effects, including muscle pain and cramping, have proven to be something of a sore point for many patients.

Read more Medical News

› Verified 7 days ago

Provider NameLinda L Hill
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1609837855
PECOS PAC ID: 9436110566
Enrollment ID: I20130918000411

News Archive

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.

The once youngest person in the world to survive a heart by-pass operation is expecting her 2nd child

Lorraine Stone was born with heart disease. When just three days old she was the youngest person in the world at that time to survive a heart by-pass operation. Since then she has had five major heart operations. Miraculously, at the age 29, she is expecting to give birth to her second child in July.

MS Australia partners again with Jean Hailes to spotlight multiple sclerosis and women's health

Multiple sclerosis affects around three times as many women as men and is commonly diagnosed between the ages of 20 and 40 years, when many women are focusing on career and family planning.

Rockefeller University Hospital opens clinical trial into statin-associated muscle complaints

The most widely prescribed class of drugs in the country, statins have helped millions of people lower their cholesterol and reduce their risk of heart attacks - but their side effects, including muscle pain and cramping, have proven to be something of a sore point for many patients.

Read more Medical News

› Verified 7 days ago

Provider NameJoseph Alfred Bousquet
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1003982174
PECOS PAC ID: 4688619679
Enrollment ID: I20141212000943

News Archive

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.

The once youngest person in the world to survive a heart by-pass operation is expecting her 2nd child

Lorraine Stone was born with heart disease. When just three days old she was the youngest person in the world at that time to survive a heart by-pass operation. Since then she has had five major heart operations. Miraculously, at the age 29, she is expecting to give birth to her second child in July.

MS Australia partners again with Jean Hailes to spotlight multiple sclerosis and women's health

Multiple sclerosis affects around three times as many women as men and is commonly diagnosed between the ages of 20 and 40 years, when many women are focusing on career and family planning.

Rockefeller University Hospital opens clinical trial into statin-associated muscle complaints

The most widely prescribed class of drugs in the country, statins have helped millions of people lower their cholesterol and reduce their risk of heart attacks - but their side effects, including muscle pain and cramping, have proven to be something of a sore point for many patients.

Read more Medical News

› Verified 7 days ago

Provider NameMinda Brown Jaramillo
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1740495753
PECOS PAC ID: 9638361538
Enrollment ID: I20150819007704

News Archive

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.

The once youngest person in the world to survive a heart by-pass operation is expecting her 2nd child

Lorraine Stone was born with heart disease. When just three days old she was the youngest person in the world at that time to survive a heart by-pass operation. Since then she has had five major heart operations. Miraculously, at the age 29, she is expecting to give birth to her second child in July.

MS Australia partners again with Jean Hailes to spotlight multiple sclerosis and women's health

Multiple sclerosis affects around three times as many women as men and is commonly diagnosed between the ages of 20 and 40 years, when many women are focusing on career and family planning.

Rockefeller University Hospital opens clinical trial into statin-associated muscle complaints

The most widely prescribed class of drugs in the country, statins have helped millions of people lower their cholesterol and reduce their risk of heart attacks - but their side effects, including muscle pain and cramping, have proven to be something of a sore point for many patients.

Read more Medical News

› Verified 7 days ago

Provider NameSherry Young
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1720167182
PECOS PAC ID: 5991705584
Enrollment ID: I20170615002010

News Archive

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.

The once youngest person in the world to survive a heart by-pass operation is expecting her 2nd child

Lorraine Stone was born with heart disease. When just three days old she was the youngest person in the world at that time to survive a heart by-pass operation. Since then she has had five major heart operations. Miraculously, at the age 29, she is expecting to give birth to her second child in July.

MS Australia partners again with Jean Hailes to spotlight multiple sclerosis and women's health

Multiple sclerosis affects around three times as many women as men and is commonly diagnosed between the ages of 20 and 40 years, when many women are focusing on career and family planning.

Rockefeller University Hospital opens clinical trial into statin-associated muscle complaints

The most widely prescribed class of drugs in the country, statins have helped millions of people lower their cholesterol and reduce their risk of heart attacks - but their side effects, including muscle pain and cramping, have proven to be something of a sore point for many patients.

Read more Medical News

› Verified 7 days ago

Provider NameGlenna Rae Tolley
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1720254816
PECOS PAC ID: 8628141355
Enrollment ID: I20190907000200

News Archive

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.

The once youngest person in the world to survive a heart by-pass operation is expecting her 2nd child

Lorraine Stone was born with heart disease. When just three days old she was the youngest person in the world at that time to survive a heart by-pass operation. Since then she has had five major heart operations. Miraculously, at the age 29, she is expecting to give birth to her second child in July.

MS Australia partners again with Jean Hailes to spotlight multiple sclerosis and women's health

Multiple sclerosis affects around three times as many women as men and is commonly diagnosed between the ages of 20 and 40 years, when many women are focusing on career and family planning.

Rockefeller University Hospital opens clinical trial into statin-associated muscle complaints

The most widely prescribed class of drugs in the country, statins have helped millions of people lower their cholesterol and reduce their risk of heart attacks - but their side effects, including muscle pain and cramping, have proven to be something of a sore point for many patients.

Read more Medical News

› Verified 7 days ago

Provider NameWilfredo Morges
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1871007377
PECOS PAC ID: 8729347257
Enrollment ID: I20190917003512

News Archive

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.

The once youngest person in the world to survive a heart by-pass operation is expecting her 2nd child

Lorraine Stone was born with heart disease. When just three days old she was the youngest person in the world at that time to survive a heart by-pass operation. Since then she has had five major heart operations. Miraculously, at the age 29, she is expecting to give birth to her second child in July.

MS Australia partners again with Jean Hailes to spotlight multiple sclerosis and women's health

Multiple sclerosis affects around three times as many women as men and is commonly diagnosed between the ages of 20 and 40 years, when many women are focusing on career and family planning.

Rockefeller University Hospital opens clinical trial into statin-associated muscle complaints

The most widely prescribed class of drugs in the country, statins have helped millions of people lower their cholesterol and reduce their risk of heart attacks - but their side effects, including muscle pain and cramping, have proven to be something of a sore point for many patients.

Read more Medical News

› Verified 7 days ago

Provider NameSandra Jensen
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1003975467
PECOS PAC ID: 1456442078
Enrollment ID: I20191017000728

News Archive

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.

The once youngest person in the world to survive a heart by-pass operation is expecting her 2nd child

Lorraine Stone was born with heart disease. When just three days old she was the youngest person in the world at that time to survive a heart by-pass operation. Since then she has had five major heart operations. Miraculously, at the age 29, she is expecting to give birth to her second child in July.

MS Australia partners again with Jean Hailes to spotlight multiple sclerosis and women's health

Multiple sclerosis affects around three times as many women as men and is commonly diagnosed between the ages of 20 and 40 years, when many women are focusing on career and family planning.

Rockefeller University Hospital opens clinical trial into statin-associated muscle complaints

The most widely prescribed class of drugs in the country, statins have helped millions of people lower their cholesterol and reduce their risk of heart attacks - but their side effects, including muscle pain and cramping, have proven to be something of a sore point for many patients.

Read more Medical News

› Verified 7 days ago

Provider NameMeeraben Majmudar
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1922372077
PECOS PAC ID: 9436432630
Enrollment ID: I20191203001139

News Archive

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.

The once youngest person in the world to survive a heart by-pass operation is expecting her 2nd child

Lorraine Stone was born with heart disease. When just three days old she was the youngest person in the world at that time to survive a heart by-pass operation. Since then she has had five major heart operations. Miraculously, at the age 29, she is expecting to give birth to her second child in July.

MS Australia partners again with Jean Hailes to spotlight multiple sclerosis and women's health

Multiple sclerosis affects around three times as many women as men and is commonly diagnosed between the ages of 20 and 40 years, when many women are focusing on career and family planning.

Rockefeller University Hospital opens clinical trial into statin-associated muscle complaints

The most widely prescribed class of drugs in the country, statins have helped millions of people lower their cholesterol and reduce their risk of heart attacks - but their side effects, including muscle pain and cramping, have proven to be something of a sore point for many patients.

Read more Medical News

› Verified 7 days ago

Provider NameMichael Hewett
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1467472480
PECOS PAC ID: 0244275014
Enrollment ID: I20200122001571

News Archive

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.

The once youngest person in the world to survive a heart by-pass operation is expecting her 2nd child

Lorraine Stone was born with heart disease. When just three days old she was the youngest person in the world at that time to survive a heart by-pass operation. Since then she has had five major heart operations. Miraculously, at the age 29, she is expecting to give birth to her second child in July.

MS Australia partners again with Jean Hailes to spotlight multiple sclerosis and women's health

Multiple sclerosis affects around three times as many women as men and is commonly diagnosed between the ages of 20 and 40 years, when many women are focusing on career and family planning.

Rockefeller University Hospital opens clinical trial into statin-associated muscle complaints

The most widely prescribed class of drugs in the country, statins have helped millions of people lower their cholesterol and reduce their risk of heart attacks - but their side effects, including muscle pain and cramping, have proven to be something of a sore point for many patients.

Read more Medical News

› Verified 7 days ago

Provider NameJane Berger
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1831557891
PECOS PAC ID: 6406286954
Enrollment ID: I20200423002038

News Archive

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.

The once youngest person in the world to survive a heart by-pass operation is expecting her 2nd child

Lorraine Stone was born with heart disease. When just three days old she was the youngest person in the world at that time to survive a heart by-pass operation. Since then she has had five major heart operations. Miraculously, at the age 29, she is expecting to give birth to her second child in July.

MS Australia partners again with Jean Hailes to spotlight multiple sclerosis and women's health

Multiple sclerosis affects around three times as many women as men and is commonly diagnosed between the ages of 20 and 40 years, when many women are focusing on career and family planning.

Rockefeller University Hospital opens clinical trial into statin-associated muscle complaints

The most widely prescribed class of drugs in the country, statins have helped millions of people lower their cholesterol and reduce their risk of heart attacks - but their side effects, including muscle pain and cramping, have proven to be something of a sore point for many patients.

Read more Medical News

› Verified 7 days ago

Provider NameAmy Susan Debernardi
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1336388198
PECOS PAC ID: 3274964275
Enrollment ID: I20200506003306

News Archive

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.

The once youngest person in the world to survive a heart by-pass operation is expecting her 2nd child

Lorraine Stone was born with heart disease. When just three days old she was the youngest person in the world at that time to survive a heart by-pass operation. Since then she has had five major heart operations. Miraculously, at the age 29, she is expecting to give birth to her second child in July.

MS Australia partners again with Jean Hailes to spotlight multiple sclerosis and women's health

Multiple sclerosis affects around three times as many women as men and is commonly diagnosed between the ages of 20 and 40 years, when many women are focusing on career and family planning.

Rockefeller University Hospital opens clinical trial into statin-associated muscle complaints

The most widely prescribed class of drugs in the country, statins have helped millions of people lower their cholesterol and reduce their risk of heart attacks - but their side effects, including muscle pain and cramping, have proven to be something of a sore point for many patients.

Read more Medical News

› Verified 7 days ago

Provider NameCarey Reed
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1962944926
PECOS PAC ID: 3678841202
Enrollment ID: I20200602001798

News Archive

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.

The once youngest person in the world to survive a heart by-pass operation is expecting her 2nd child

Lorraine Stone was born with heart disease. When just three days old she was the youngest person in the world at that time to survive a heart by-pass operation. Since then she has had five major heart operations. Miraculously, at the age 29, she is expecting to give birth to her second child in July.

MS Australia partners again with Jean Hailes to spotlight multiple sclerosis and women's health

Multiple sclerosis affects around three times as many women as men and is commonly diagnosed between the ages of 20 and 40 years, when many women are focusing on career and family planning.

Rockefeller University Hospital opens clinical trial into statin-associated muscle complaints

The most widely prescribed class of drugs in the country, statins have helped millions of people lower their cholesterol and reduce their risk of heart attacks - but their side effects, including muscle pain and cramping, have proven to be something of a sore point for many patients.

Read more Medical News

› Verified 7 days ago

Provider NameCynthia A Ziemer
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1003039074
PECOS PAC ID: 9335394659
Enrollment ID: I20201106000087

News Archive

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.

The once youngest person in the world to survive a heart by-pass operation is expecting her 2nd child

Lorraine Stone was born with heart disease. When just three days old she was the youngest person in the world at that time to survive a heart by-pass operation. Since then she has had five major heart operations. Miraculously, at the age 29, she is expecting to give birth to her second child in July.

MS Australia partners again with Jean Hailes to spotlight multiple sclerosis and women's health

Multiple sclerosis affects around three times as many women as men and is commonly diagnosed between the ages of 20 and 40 years, when many women are focusing on career and family planning.

Rockefeller University Hospital opens clinical trial into statin-associated muscle complaints

The most widely prescribed class of drugs in the country, statins have helped millions of people lower their cholesterol and reduce their risk of heart attacks - but their side effects, including muscle pain and cramping, have proven to be something of a sore point for many patients.

Read more Medical News

› Verified 7 days ago

Provider NameStephany Boafo Gyasi
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1508369166
PECOS PAC ID: 1355603663
Enrollment ID: I20210930002626

News Archive

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.

The once youngest person in the world to survive a heart by-pass operation is expecting her 2nd child

Lorraine Stone was born with heart disease. When just three days old she was the youngest person in the world at that time to survive a heart by-pass operation. Since then she has had five major heart operations. Miraculously, at the age 29, she is expecting to give birth to her second child in July.

MS Australia partners again with Jean Hailes to spotlight multiple sclerosis and women's health

Multiple sclerosis affects around three times as many women as men and is commonly diagnosed between the ages of 20 and 40 years, when many women are focusing on career and family planning.

Rockefeller University Hospital opens clinical trial into statin-associated muscle complaints

The most widely prescribed class of drugs in the country, statins have helped millions of people lower their cholesterol and reduce their risk of heart attacks - but their side effects, including muscle pain and cramping, have proven to be something of a sore point for many patients.

Read more Medical News

› Verified 7 days ago

Provider NameMarie Natacha Francis
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1689043465
PECOS PAC ID: 9335438001
Enrollment ID: I20210930002765

News Archive

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.

The once youngest person in the world to survive a heart by-pass operation is expecting her 2nd child

Lorraine Stone was born with heart disease. When just three days old she was the youngest person in the world at that time to survive a heart by-pass operation. Since then she has had five major heart operations. Miraculously, at the age 29, she is expecting to give birth to her second child in July.

MS Australia partners again with Jean Hailes to spotlight multiple sclerosis and women's health

Multiple sclerosis affects around three times as many women as men and is commonly diagnosed between the ages of 20 and 40 years, when many women are focusing on career and family planning.

Rockefeller University Hospital opens clinical trial into statin-associated muscle complaints

The most widely prescribed class of drugs in the country, statins have helped millions of people lower their cholesterol and reduce their risk of heart attacks - but their side effects, including muscle pain and cramping, have proven to be something of a sore point for many patients.

Read more Medical News

› Verified 7 days ago

Provider NameViolet Ashu
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1881278240
PECOS PAC ID: 0941697072
Enrollment ID: I20220420000806

News Archive

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.

The once youngest person in the world to survive a heart by-pass operation is expecting her 2nd child

Lorraine Stone was born with heart disease. When just three days old she was the youngest person in the world at that time to survive a heart by-pass operation. Since then she has had five major heart operations. Miraculously, at the age 29, she is expecting to give birth to her second child in July.

MS Australia partners again with Jean Hailes to spotlight multiple sclerosis and women's health

Multiple sclerosis affects around three times as many women as men and is commonly diagnosed between the ages of 20 and 40 years, when many women are focusing on career and family planning.

Rockefeller University Hospital opens clinical trial into statin-associated muscle complaints

The most widely prescribed class of drugs in the country, statins have helped millions of people lower their cholesterol and reduce their risk of heart attacks - but their side effects, including muscle pain and cramping, have proven to be something of a sore point for many patients.

Read more Medical News

› Verified 7 days ago

Provider NameIjeoma Uchegbu
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1336648625
PECOS PAC ID: 9638550155
Enrollment ID: I20220801000928

News Archive

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.

The once youngest person in the world to survive a heart by-pass operation is expecting her 2nd child

Lorraine Stone was born with heart disease. When just three days old she was the youngest person in the world at that time to survive a heart by-pass operation. Since then she has had five major heart operations. Miraculously, at the age 29, she is expecting to give birth to her second child in July.

MS Australia partners again with Jean Hailes to spotlight multiple sclerosis and women's health

Multiple sclerosis affects around three times as many women as men and is commonly diagnosed between the ages of 20 and 40 years, when many women are focusing on career and family planning.

Rockefeller University Hospital opens clinical trial into statin-associated muscle complaints

The most widely prescribed class of drugs in the country, statins have helped millions of people lower their cholesterol and reduce their risk of heart attacks - but their side effects, including muscle pain and cramping, have proven to be something of a sore point for many patients.

Read more Medical News

› Verified 7 days ago

Provider NameGlenn Ferguson
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1922391994
PECOS PAC ID: 3870771496
Enrollment ID: I20230104001480

News Archive

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.

The once youngest person in the world to survive a heart by-pass operation is expecting her 2nd child

Lorraine Stone was born with heart disease. When just three days old she was the youngest person in the world at that time to survive a heart by-pass operation. Since then she has had five major heart operations. Miraculously, at the age 29, she is expecting to give birth to her second child in July.

MS Australia partners again with Jean Hailes to spotlight multiple sclerosis and women's health

Multiple sclerosis affects around three times as many women as men and is commonly diagnosed between the ages of 20 and 40 years, when many women are focusing on career and family planning.

Rockefeller University Hospital opens clinical trial into statin-associated muscle complaints

The most widely prescribed class of drugs in the country, statins have helped millions of people lower their cholesterol and reduce their risk of heart attacks - but their side effects, including muscle pain and cramping, have proven to be something of a sore point for many patients.

Read more Medical News

› Verified 7 days ago

News Archive

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.

The once youngest person in the world to survive a heart by-pass operation is expecting her 2nd child

Lorraine Stone was born with heart disease. When just three days old she was the youngest person in the world at that time to survive a heart by-pass operation. Since then she has had five major heart operations. Miraculously, at the age 29, she is expecting to give birth to her second child in July.

MS Australia partners again with Jean Hailes to spotlight multiple sclerosis and women's health

Multiple sclerosis affects around three times as many women as men and is commonly diagnosed between the ages of 20 and 40 years, when many women are focusing on career and family planning.

Rockefeller University Hospital opens clinical trial into statin-associated muscle complaints

The most widely prescribed class of drugs in the country, statins have helped millions of people lower their cholesterol and reduce their risk of heart attacks - but their side effects, including muscle pain and cramping, have proven to be something of a sore point for many patients.

Read more News

› Verified 7 days ago

Psychiatry & Neurology in Espanola, NM

Peak Behavioral Health Services, Llc
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 1316 Calle Adelante, Espanola, NM 87532
Phone: 575-589-6720    
Superhealth, Inc.
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 19 Lumbre Del Sol, Espanola, NM 87532
Phone: 505-699-6505    
Rio Arriba County Hhs
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2010 Industrial Park Rd, Espanola, NM 87532
Phone: 505-753-3143    
Guillermina Osoria
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 424 S Riverside Dr Ste G, Espanola, NM 87532
Phone: 505-595-4848    Fax: 888-504-0115
Time 4 Change, Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 19525 Tomas Lane, Espanola, NM 87532
Phone: 505-709-0608    
Crisis Center Of Nnm
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 577 El Llano Rd, Espanola, NM 87532
Phone: 505-753-1656    Fax: 505-753-7743
Simran Center For Health & Psychology
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 27 Shady Ln, Espanola, NM 87532
Phone: 505-753-4692    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.